U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

The Decision-Point Approach for Systematic Carcinogen Testing



Details

  • Personal Author:
  • Description:
    Advances in the understanding of the mechanisms of chemical carcinogenesis suggest new approaches to the practical aspects of the bioassay of carcinogens and regulatory impact, and to the determination of health risk. Chemical carcinogens have been classified into two main types on the basis of their specific properties: (1) genotoxic carcinogens; (2) agents operating by epigenetic mechanisms. Current concepts indicate that genotoxic carcinogens require distinct qualitative and quantitative types of analysis since their fundamental mechanisms of operation are different from those of epigenetic agents. A systematic 'decision-point approach' to carcinogen testing provides for distinction between genotoxic and epigenetic carcinogens. The first set of data points involves the following: (1) structure-activity relationships; (2) mutagenicity assays in prokaryotes; (3) mutagenicity assays in eukaryotes; (4) tests for induction of DNA repair in eukaryotes; (5) tests for sister chromatid exchange; (6) cell transformation. Not all of these have equal sensitivity, specificity and reliability. The sequence of in vitro tests permits preliminary decision making. As a second series, limited, relatively rapid, in vivo assays involve the following: (1) skin-tumour induction in mice, with and without promotion; (2) lung-tumour induction in mice; (3) breast-cancer induction in rats; (4) identification of early lesions in rodent liver. The data so obtained are considered for decision making and risk analysis. As a last step, a traditional chronic bioassay may be needed only when human exposure to the product is potentially high and/or continuous, or when the above phases of testing have yielded unsatisfactory or, in the case of epigenetic agents, negative results. More research is essential for the delineation of the effects of epigenetic agents, some of which are most important in the aetiology of human cancer. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0015-6264
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    19
  • Issue:
    5
  • NIOSHTIC Number:
    nn:20061145
  • Citation:
    Food Cosmet Toxicol 1981 Oct; 19(5):561-566
  • Federal Fiscal Year:
    1982
  • Performing Organization:
    American Health Foundation, Valhalla, New York
  • Peer Reviewed:
    True
  • Start Date:
    19751201
  • Source Full Name:
    Food and Cosmetics Toxicology
  • End Date:
    19811130
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:6dc191902abf9de593c6b0107b8070cce0bf00dfae04f7202a117893dca98e23afb161189ceae55a45ca6b3d3fcaf14559af9e4786e6f50fcba2b741da58f1f3
  • Download URL:
  • File Type:
    Filetype[PDF - 579.58 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.